----

|                          |
|--------------------------|
|                          |  |
| 001-10315                | 63-0860407 |
| (Commission File Number) | (IRS Employer Identification No.) |
|                     |   |

|        |
|--------|
|        |  |
| ¨ | Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|   |   |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|   |   |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|   |   |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

----

----

|         |                                                                                                                                                                                                                                                                              |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | The Company expects to report solid volume growth for the second quarter of 2015, including discharges from its recently closed acquisition of Cardinal Hill Rehabilitation Hospital in Lexington, Kentucky and its joint venture with Memorial Health in Savannah, Georgia. |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Based on the Supplemental Security Income, or “SSI,” ratios recently published by the Centers for Medicare and Medicaid Services (“CMS”) for fiscal year 2013, the Company expects Adjusted EBITDA in the second quarter of 2015 to be negatively impacted by approximately $4 million to $5 million reflecting retroactive adjustments for full-year 2013, full-year 2014, and year-to-date 2015. CMS periodically retroactively updates SSI ratios that are used to determine adjustments to Medicare payment rates for low-income patients. |

----

----

|                                                                              |
|------------------------------------------------------------------------------|
|                                                                              |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                         | Three Months Ended March 31, |   | Year Ended December 31, |
|                                                                         |   |
|                                                                         | 2015 |   | 2014 |   | 2014 |   | 2013 |
|                                                                         | (In Millions) |
| Net cash provided by operating activities                                    | $ | 102.0 |  |   | $ | 107.1 |  |   | $ | 444.9 |  |   | $ | 470.3 |  |
| Provision for doubtful accounts                                              | (11.6 | ) |   | (7.5 | ) |   | (31.6 | ) |   | (26.0 | ) |
| Professional fees—accounting, tax, and legal                           | 2.2 |  |   | 1.6 |  |   | 9.3 |  |   | 9.5 |  |
| Interest expense and amortization of debt discounts and fees                 | 31.8 |  |   | 27.9 |  |   | 109.2 |  |   | 100.4 |  |
| Equity in net income of nonconsolidated affiliates                           | 1.6 |  |   | 4.3 |  |   | 10.7 |  |   | 11.2 |  |
| Net income attributable to noncontrolling interests in continuing operations | (16.5 | ) |   | (14.8 | ) |   | (59.7 | ) |   | (57.8 | ) |
| Amortization of debt-related items                                           | (3.3 | ) |   | (3.1 | ) |   | (12.7 | ) |   | (5.0 | ) |
| Distributions from nonconsolidated affiliates                                | (1.9 | ) |   | (3.4 | ) |   | (12.6 | ) |   | (11.4 | ) |
| Current portion of income tax expense                                        | 3.5 |  |   | 3.6 |  |   | 13.3 |  |   | 6.3 |  |
| Change in assets and liabilities                                             | 56.0 |  |   | 26.9 |  |   | 90.1 |  |   | 48.9 |  |
| Net premium (received) paid on bond transactions                             | (8.0 | ) |   | — |  |   | 4.3 |  |   | 1.7 |  |
| Cash used in operating activities of discontinued operations                 | 0.1 |  |   | 0.2 |  |   | 1.2 |  |   | 1.9 |  |
| Encompass transaction costs                                                  | — |  |   | — |  |   | 9.3 |  |   | — |  |
| Other                                                                        | 0.2 |  |   | 1.3 |  |   | 1.9 |  |   | 1.6 |  |
| Adjusted EBITDA                                                              | $ | 156.1 |  |   | $ | 144.1 |  |   | $ | 577.6 |  |   | $ | 551.6 |  |

----

|                                                              |
|--------------------------------------------------------------|
|                                                              |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                         | Q1 2015 |   | Q4 2014 |   | Q3 2014 |   | Q2 2014 |   | Q1 2014 |   | Full-Year 2014 |
|                                                         | In Millions |
| Total segment Adjusted EBITDA                                | $ | 181.3 |  |   | $ | 163.3 |  |   | $ | 162.5 |  |   | $ | 175.9 |  |   | $ | 167.5 |  |   | $ | 669.2 |  |
| General and administrative expenses                          | (34.6 | ) |   | (36.4 | ) |   | (27.5 | ) |   | (30.2 | ) |   | (30.7 | ) |   | (124.8 | ) |
| Depreciation and amortization                                | (31.9 | ) |   | (27.5 | ) |   | (27.4 | ) |   | (26.4 | ) |   | (26.4 | ) |   | (107.7 | ) |
| Gain (loss) on disposal or impairment of assets              | 1.5 |  |   | (1.0 | ) |   | (2.7 | ) |   | (1.7 | ) |   | (1.3 | ) |   | (6.7 | ) |
| Government, class action, and related settlements            | (8.0 | ) |   | 0.9 |  |   | — |  |   | 0.8 |  |   | — |  |   | 1.7 |  |
| Professional fees - accounting, tax, and legal               | (2.2 | ) |   | (1.7 | ) |   | (4.0 | ) |   | (2.0 | ) |   | (1.6 | ) |   | (9.3 | ) |
| Loss on early extinguishment of debt                         | (1.2 | ) |   | (13.2 | ) |   | — |  |   | — |  |   | — |  |   | (13.2 | ) |
| Interest expense and amortization of debt discounts and fees | (31.8 | ) |   | (25.7 | ) |   | (27.8 | ) |   | (27.8 | ) |   | (27.9 | ) |   | (109.2 | ) |
| Gain on consolidation of former equity method hospital       | — |  |   | — |  |   | — |  |   | 27.2 |  |   | — |  |   | 27.2 |  |
| Net income attributable to noncontrolling interests          | 16.5 |  |   | 15.4 |  |   | 14.7 |  |   | 14.8 |  |   | 14.8 |  |   | 59.7 |  |
| Income from continuing operations before income tax expense  | $ | 89.6 |  |   | $ | 74.1 |  |   | $ | 87.8 |  |   | $ | 130.6 |  |   | $ | 94.4 |  |   | $ | 386.9 |  |

----

|      |                                                                                                                                                 |
|------|-------------------------------------------------------------------------------------------------------------------------------------------------|
| 99.1 | Investor Day Slides of HealthSouth Corporation used in connection with its June 10, 2015 presentation at its investor meeting in New York City. |

----

|        |
|--------|
|        |  |  |
|   |   |   |
| By:    | /S/   JOHN P. WHITTINGTON |
|   | Name: | John P. Whittington |
|   | Title: | Executive Vice President, General Counseland Corporate Secretary |